Rakesh Verma

Title: Rakesh Verma: Innovator in Cancer Treatment

Introduction

Rakesh Verma is a notable inventor based in London, GB. He has made significant contributions to the field of medicine, particularly in cancer treatment. His innovative work has led to the development of a unique patent that showcases his expertise and dedication to advancing medical science.

Latest Patents

Rakesh Verma holds a patent for "Interleukin-12 targeted to oncofoetal fibronectin." This invention provides a compound that includes a target-specific portion and an effector portion. The target-specific portion consists of a monoclonal antibody that has specificity for oncofoetal fibronectin, or a fragment or variant that retains the antigen-binding specificity of the parent monoclonal antibody. The effector portion comprises interleukin-12 or a functional fragment or variant thereof. Notably, the monoclonal antibody binds to a region of oncofoetal fibronectin other than the ED-B region. This invention also includes nucleic acids encoding the compounds and their use in medicine, particularly in cancer treatment. Rakesh Verma has 1 patent to his name.

Career Highlights

Throughout his career, Rakesh Verma has worked with several prominent companies in the research sector. He has been associated with Antisoma Research Limited and Emd Serono Research Center, Inc. His work in these organizations has contributed to the advancement of cancer therapies and innovative medical solutions.

Collaborations

Rakesh Verma has collaborated with notable professionals in his field, including Stephen D Gillies and Kin-Ming Lo. These collaborations have further enriched his research and development efforts, leading to impactful innovations in cancer treatment.

Conclusion

Rakesh Verma is a distinguished inventor whose work in cancer treatment has made a significant impact on medical science. His innovative patent and collaborations highlight his commitment to advancing healthcare solutions.